Holen Sie sich die Stockscreener-App
6.03
1.34%
0.08
Handel nachbörslich:
6.03
Schlusskurs vom Vortag:
$5.95
Offen:
$5.99
24-Stunden-Volumen:
553.98K
Relative Volume:
0.83
Marktkapitalisierung:
$766.42M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-150.75
EPS:
-0.04
Netto-Cashflow:
$454.00K
1W Leistung:
-15.66%
1M Leistung:
+16.63%
6M Leistung:
-1.15%
1J Leistung:
+0.84%
1-Tages-Spanne:
$5.905
$6.10
1-Wochen-Bereich:
$5.90
$7.23
52-Wochen-Spanne:
$4.66
$9.87
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Vergleichen Sie CTKB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CTKB | 6.03 | 766.42M | 193.01M | -12.15M | 454.00K | -0.04 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
Cytek Biosciences, Inc. (NASDAQ:CTKB) Sees Large Decline in Short Interest - MarketBeat
Brown Capital Management LLC Adjusts Stake in Cytek Biosciences Inc - GuruFocus.com
Piper Sandler Forecasts Strong Price Appreciation for Cytek Biosciences (NASDAQ:CTKB) Stock - Defense World
CTKBCytek Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
Cytek Biosciences Inc. (CTKB) Quarterly 10-Q Report - Quartzy
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter - GlobeNewswire
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2024 Earnings Call Transcript - Insider Monkey
Investors Still Aren't Entirely Convinced By Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Revenues Despite 46% Price Jump - Simply Wall St
Cytek Biosciences Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Cytek Biosciences (NASDAQ:CTKB) Shares Up 26.7% After Strong Earnings - Defense World
Earnings call: Cytek Biosciences reports steady growth in Q3 2024 By Investing.com - Investing.com South Africa
Earnings call: Cytek Biosciences reports steady growth in Q3 2024 - Investing.com
Cytek Biosciences (NASDAQ:CTKB) Shares Up 26.7% After Earnings Beat - MarketBeat
U.S. Stock market: SONN(+86.46%), DataChat(+50.28%), Cytek Biosciences(+30.51%) among the top gainers during early trading - Business Upturn
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings Call Highlights: Revenue Growth and Positive Net ... By GuruFocus - Investing.com Canada
Cytek Biosciences Reports Third Quarter 2024 Financial Results - GlobeNewswire
Cytek Biosciences’ Q3 2024 Financial Highlights - TipRanks
Cytek Biosciences, Inc. (CTKB) Q3 Earnings and Revenues Beat Estimates - MSN
Cytek Biosciences earnings matched, revenue topped estimates - Investing.com
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings: Revenue Hits $51. - GuruFocus.com
Cytek Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Preview: Cytek Biosciences's Earnings - Benzinga
What To Expect From Cytek Biosciences Inc (CTKB) Q3 2024 Earnings - Yahoo Finance
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Cytek Biosciences (CTKB) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024 - GlobeNewswire
Cytek® Biosciences automates panel design with new intelligent algorithm - MSN
Layoff Tracker: Dublin-Based CRO With US Offices Signals Upcoming Layoffs - BioSpace
(CTKB) Trading Report - Stock Traders Daily
The Manufacturers Life Insurance Company Purchases 2,460 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Up 5.4% in September - MarketBeat
Institutional investors have a lot riding on Cytek Biosciences, Inc. (NASDAQ:CTKB) with 53% ownership - Simply Wall St
What technical indicators reveal about CTKB stock - US Post News
Cytek BioSciences Inc (CTKB) Becoming More Attractive for Investors - Knox Daily
Millennium Management LLC Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Shares Up 3.6%Still a Buy? - MarketBeat
Analysts review Cytek BioSciences Inc’s rating - Knox Daily
Examining Cytek BioSciences Inc (CTKB) more closely is necessary - US Post News
Quarterly Snapshot: Quick and Current Ratios for Cytek BioSciences Inc (CTKB) - The Dwinnex
When the Price of (CTKB) Talks, People Listen - Stock Traders Daily
Squarepoint Ops LLC Acquires 170,539 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Renaissance Technologies LLC Makes New $1.31 Million Investment in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Algert Global LLC - MarketBeat
Selling Buzz: Cytek BioSciences Inc [CTKB] CHIEF TECHNOLOGY OFFICER Yan Ming sells 20,000 shares of the company – Knox Daily - Knox Daily
Cytek BioSciences Inc (CTKB) can make a big difference with a little luck - SETE News
Stock Performance Spotlight: Cytek BioSciences Inc (CTKB) Ends the Day at 5.24, Down by -2.78 - The Dwinnex
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by Public Sector Pension Investment Board - Defense World
American Century Companies Inc. Increases Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Dark Forest Capital Management LP Purchases 9,711 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Technical analysis of Cytek BioSciences Inc (CTKB) stock chart patterns - US Post News
Deerfield Management Company L.P. Series C Purchases Shares of 155,759 Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cytek Biosciences Inc-Aktie (CTKB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Apr 09 '24 |
Sale |
7.00 |
1,900 |
13,304 |
6,008,502 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Mar 18 '24 |
Sale |
6.77 |
20,000 |
135,400 |
6,030,402 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Mar 19 '24 |
Sale |
6.71 |
20,000 |
134,200 |
6,010,402 |
| Jeanmonod Patrik | Chief Financial Officer |
Dec 26 '23 |
Sale |
9.50 |
3,000 |
28,500 |
93,400 |
| Yan Ming | Chief Technology Officer |
Dec 19 '23 |
Sale |
9.43 |
20,000 |
188,600 |
6,042,103 |
| Jeanmonod Patrik | Chief Financial Officer |
Nov 24 '23 |
Sale |
6.94 |
3,000 |
20,820 |
96,400 |
| Yan Ming | Chief Technology Officer |
Nov 20 '23 |
Sale |
6.03 |
20,000 |
120,600 |
7,762,103 |
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):